文献速递血管炎其他结缔组织病

原发性系统性血管炎的肺部受累表现

Pulmonary involvement in primary systemic vasculitides.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究基于DCVAS研究数据,描述了1952例原发性系统性血管炎患者的肺部表现。结果显示肺部受累可见于所有类型血管炎,但在ANCA相关性血管炎中更常见且更易导致永久性损伤。

要点

  • 肺部表现可见于所有原发性系统性血管炎,但AAV中频率最高。
  • 6个月时EGPA患者VDI肺部条目出现比例最高(52.7%)。

核心结论

  • 肺部表现可发生于所有原发性系统性血管炎,但在ANCA相关性血管炎中更频繁且更常与永久性损伤相关。

研究设计与样本

  • 基于血管炎诊断与分类标准研究(DCVAS)数据,描述并比较1952例成人原发性血管炎患者的肺部表现。

主要发现

  • 肺部表现见于TAK(21.8%)、GCA(15.8%)、GPA(64.5%)、MPA(65.9%)、EGPA(89.0%)、PAN(27.1%)和IgAV(5.9%)患者。
  • 呼吸困难见于TAK(14.7%)、GCA(7.8%)、GPA(41.8%)、MPA(43.5%)、EGPA(65.8%)、PAN(18.8%)和IgAV(2.6%)患者。
  • 咳嗽见于TAK(7.6%)、GCA(9.3%)、GPA(34.8%)、MPA(37.7%)、EGPA(55.5%)、PAN(16.7%)和IgAV(3.3%)患者。
  • 咯血主要发生于ANCA相关性血管炎患者。
  • 诊断时影像学纤维化见于GPA(1.9%)、MPA(24.9%)和EGPA(6.3%)患者,仅AAV患者需要机械通气(GPA 2.7%、MPA 2.7%、EGPA 3.4%)。

关键数值与推荐

  • 6个月时血管炎损伤指数(VDI)至少一项肺部条目见于TAK(4.1%)、GCA(3.3%)、GPA(15.4%)、MPA(28.7%)、EGPA(52.7%)、PAN(6.2%)和IgAV(1.3%)患者。

临床怎么用

  • 对原发性系统性血管炎患者应评估肺部受累,尤其AAV患者需警惕永久性肺损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study describes the spectrum and initial impact of pulmonary manifestations in the primary systemic vasculitides. METHODS: Description and comparison of pulmonary manifestations in adults with Takayasu's arteritis (TAK), GCA, granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), eosinophilic GPA (EGPA), polyarteritis nodosa (PAN) and IgA vasculitis (IgAV), using data collected within the Diagnostic and Classification Criteria in Vasculitis study. RESULTS: Data from 1952 patients with primary vasculitides were included: 170 TAK, 657 GCA, 555 GPA, 223 MPA, 146 EGPA, 153 IgAV and 48 PAN. Pulmonary manifestations were observed in patients with TAK (21.8%), GCA (15.8%), GPA (64.5%), MPA (65.9%), EGPA (89.0%), PAN (27.1%) and IgAV (5.9%). Dyspnoea occurred in patients with TAK (14.7%), GCA (7.8%), GPA (41.8%), MPA (43.5%), EGPA (65.8%), PAN (18.8%) and IgAV (2.6%). Cough was reported in TAK (7.6%), GCA (9.3%), GPA (34.8%), MPA (37.7%), EGPA (55.5%), PAN (16.7%) and IgAV (3.3%). Haemoptysis occurred mainly in patients with ANCA-associated vasculitis (AAV). Fibrosis on imaging at diagnosis was documented in GPA (1.9%), MPA (24.9%) and EGPA (6.3%). Only patients with AAV (GPA 2.7%, MPA 2.7% and EGPA 3.4%) required mechanical ventilation. At 6 months, the presence of at least one pulmonary item in the Vasculitis Damage Index was observed in TAK (4.1%), GCA (3.3%), GPA (15.4%), MPA (28.7%), EGPA (52.7%), PAN (6.2%) and IgAV (1.3%). CONCLUSION: Pulmonary manifestations can occur in all primary systemic vasculitides, but are more frequent and more often associated with permanent damage in AAV.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Makhzoum JP, Grayson PC, Ponte C, et al. Pulmonary involvement in primary systemic vasculitides. Rheumatology (Oxford). 2021. PMID: 33788906. doi:10.1093/rheumatology/keab325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。